PCI No Riskier With Plavix Plus Statins, CCBs (CME/CE)

(MedPage Today) -- Patients undergoing percutaneous coronary intervention did not have an increased risk of cardiovascular events if they received clopidogrel against a background of statin or calcium channel blocker therapy, a large clinical trial showed.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news